Clinical Trials

258 enrolled

Phase 3 Not yet recruiting

Multiple Myeloma

NCT07393282 2026-03-16

LINKER-SMM2

270 enrolled

Smoldering Multiple Myeloma, Multiple Myeloma

NCT07454187 2026-03-06

To Evaluate the Safety of SG2918 in Patients With Relapsed/Refractory Multiple Myeloma

40 enrolled

Multiple Myeloma

NCT07455851 2026-03-06

A Trial to Study if REGN17372 in Combination With Linvoseltamab is Tolerable for Adult Participants With Relapsed/Refractory Multiple Myeloma

150 enrolled

Multiple Myeloma

NCT07336472 2026-02-25

A Study of IBI3003 in Subjects With Relapsed or Refractory Multiple Myeloma

360 enrolled

Phase 2/3 Not yet recruiting

Multiple Myeloma

NCT07428369 2026-02-23

LINKER-MM8

1,570 enrolled

Multiple Myeloma

NCT07421856 2026-02-19

Phase I/II Study of SENL103 for Relapsed or Refractory Multiple Myeloma: A Multicenter, Open-Label, Single-Arm Trial.

24 enrolled

Multiple Myeloma

NCT07391761 2026-02-18

A Real World Study of Elranatamab in Patients With RR Multiple Myeloma in Taiwan

30 enrolled

Multiple Myeloma

NCT07409246 2026-02-13

A Study to Evaluate the, Adverse Events, Change in Disease Activity, Tolerability, and How Intravenous ABBV-438 Moves Through the Body in Adult Participants With Multiple Myeloma (MM)

127 enrolled

Multiple Myeloma, Neoplasms

NCT07400744 2026-02-10

A Study to Compare the PK , Safety, and Immunogenicity of QL2109 With Daratumumab in Male Subjects

102 enrolled

Multiple Myeloma

NCT07354555 2026-01-21

MMExFFPE

15 enrolled

Multiple Myeloma, Neoplasms, Plasma Cell

NCT07255898 2025-12-01

A Study of BL-M24D1 in Patients With Relapsed or Refractory Multiple Myeloma and Other Hematologic Malignancies

Other hematologic neoplasmPlasma cell

33 enrolled

Multiple Myeloma, Hematologic Neoplasms

NCT07227311 2025-11-12

A Study to Evaluate the Efficacy and Safety of Belantamab Mafodotin in Combination With Standard of Care in Participants With Relapsed-Refractory Multiple Myeloma (RRMM)

Phase 2 Not yet recruiting

200 enrolled

Phase NA Not yet recruiting

Multiple Myeloma

NCT07195617 2025-09-26

r/r MM

10 enrolled

Phase 3 Not yet recruiting

Multiple Myeloma

NCT07181239 2025-09-18

Study of CM336 in Relapsed or Refractory Multiple Myeloma Patients

280 enrolled

Multiple Myeloma

NCT07107204 2025-09-17

A Clinical Study of BT02 in Patients With Relapsed or Refractory Hematologic Malignancies

LymphoidOther hematologic neoplasmPlasma cell

116 enrolled

Leukemia, Lymphoma, Multiple Myeloma, Recurrence, Hematologic Neoplasms

NCT07090954 2025-07-29

A Study of GR1803 Injection in Combination With Anti-CD38 Monoclonal Antibody for the Treatment of Participants With Multiple Myeloma

32 enrolled

Multiple Myeloma

NCT06825845 2025-02-13

Long Term Follow-up Observational Study in Patients Treated with Gene-Modified T-Cell Therapy

1,500 enrolled

Phase 3 Not yet recruiting

Multiple Myeloma, Recurrence

NCT06742138 2024-12-19

To Evaluate the Efficacy and Safety of QL2109 and DARZALEX FASPRO® in Multiple Myeloma

284 enrolled

Multiple Myeloma

NCT06705725 2024-11-26

Phase I Clinical Study of CBG002 CAR-T Cell in Treatment of Relapsed/refractory Multiple Myeloma

38 enrolled

Multiple Myeloma

NCT06323447 2024-10-09

PC002

210 enrolled

LymphoidPlasma cell

Multiple Myeloma, Lymphoma, Large B-Cell, Diffuse

NCT06500507 2024-07-15

A Study of QLS4131 in Patients With Recurrent or Refractory Multiple Myeloma

90 enrolled

Phase 4 Not yet recruiting

Multiple Myeloma, Recurrence

NCT05545202 2024-04-03

A Randomized, Comparative, Double-blind Trial of Pentaisomaltose and Dimethyl Sulphoxide for Cryoprotection of Hematopoietic Stem Cells in Subjects With Multiple Myeloma or Malignant Lymphoma With a Need for Autologous Transplantation

150 enrolled

LymphoidPlasma cell

Lymphoma, Multiple Myeloma

NCT06333509 2024-03-27

Anti-GPRC5D CAR-T Cells (CT071) in Participants With RRMM or RRpPCL

Other hematologic neoplasmPlasma cell

166 enrolled

Multiple Myeloma, Hematologic Neoplasms

NCT05860179 2023-05-23

Examination of Trends in Multiple Myeloma Trial Patient Experiences

500 enrolled

Multiple Myeloma

NCT05181501 2022-01-06

A Study of Fully Human BCMA CAR-T (CT103A) in Patients With Newly Diagnosed High-risk Multiple Myeloma (FUMANBA-2)

20 enrolled

Multiple Myeloma

NCT05055791 2021-09-24

A Study to Evaluate the Safety and Tolerance of SYHX1903 in Patients With Relapsed/Refractory Hematologic Malignancies